Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | HIV Drug | Research article

HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China

Authors: Xianwu Pang, Kailing Tang, Qin He, Jinghua Huang, Ningye Fang, Xinjuan Zhou, Qiuying Zhu, Xiuling Wu, Zhiyong Shen, Shujia Liang

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

The widespread use of antiretroviral therapy (ART) has resulted in the development of transmitted drug resistance (TDR), which reduces ART efficacy. We explored TDR prevalence and its associated risk factors in newly diagnosed individuals in Guangxi.

Methods

We enrolled 1324 participants who were newly diagnosed with HIV-1 and had not received ART at voluntary counselling and testing centres (VCT) in Guangxi, China, who had not received ART. Phylogenetic relationship, transmission cluster, and genotypic drug resistance analyses were performed using HIV-1 pol sequences. We analysed the association of demographic and virological factors with TDR.

Results

In total, 1151 sequences were sequenced successfully, of which 83 (7.21%) showed evidence of TDR. Multivariate logistic regression analysis revealed that there was significant difference between the prevalence of TDR and unmarried status (adjusted odds ratio (aOR) = 2.41, 95% CI: 1.23–4.71), and CRF08_BC subtype (aOR = 2.03, 95% CI: 1.13–3.64). Most cases of TDR were related to resistance to non-nucleoside reverse transcriptase inhibitors (4.87%) and V179E was the most common mutation detected. We identified a total of 119 HIV transmission clusters (n = 585, 50.8%), of which 18 (15.1%) clusters showed evidence of TDR (36, 41.86%). Three clusters were identified that included drug-resistant individuals having a transmission relationship with each other. The following parameters were associated with TDR transmission risk: Unmarried status, educational level of junior high school or below, and CRF08_BC subtype may be a risk of the transmission of TDR.

Conclusions

Our findings indicated that moderate TDR prevalence and highlighted the importance of continuous TDR monitoring and designing of strategies for TDR mitigation.
Literature
1.
go back to reference Ge XM, Yang WM, Zhu QY, Wu WL, Shen ZY, Zhu JH, et al. Epidemiological characteristics of HIV/AIDS in Guangxi Zhuang autonomous region, 2010-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:315–21.PubMed Ge XM, Yang WM, Zhu QY, Wu WL, Shen ZY, Zhu JH, et al. Epidemiological characteristics of HIV/AIDS in Guangxi Zhuang autonomous region, 2010-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:315–21.PubMed
2.
go back to reference Chen J, Young NL, Subbarao S, Warachit P, Saguanwongse S, Wongsheree S, et al. HIV type 1 subtypes in Guangxi Province, China, 1996. AIDS Res Hum Retrov. 1999;15:81–4.CrossRef Chen J, Young NL, Subbarao S, Warachit P, Saguanwongse S, Wongsheree S, et al. HIV type 1 subtypes in Guangxi Province, China, 1996. AIDS Res Hum Retrov. 1999;15:81–4.CrossRef
3.
go back to reference Huang Y, Zhou O, Zheng Z, Xu Y, Shao Y, Qin C, et al. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study. AIDS Res Ther. 2020;17:44.CrossRef Huang Y, Zhou O, Zheng Z, Xu Y, Shao Y, Qin C, et al. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study. AIDS Res Ther. 2020;17:44.CrossRef
4.
go back to reference Hao M, Wang J, Xin R, Li X, Hao Y, Chen J, et al. Low rates of transmitted drug resistances among treatment-naive HIV-1-infected students in Beijing. China AIDS Res Hum Retrovir. 2017;33:970–6.CrossRef Hao M, Wang J, Xin R, Li X, Hao Y, Chen J, et al. Low rates of transmitted drug resistances among treatment-naive HIV-1-infected students in Beijing. China AIDS Res Hum Retrovir. 2017;33:970–6.CrossRef
5.
go back to reference Viviane DL, Richard H, David RB, Robert SH, Robert G, Benita YJ, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36.CrossRef Viviane DL, Richard H, David RB, Robert SH, Robert G, Benita YJ, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36.CrossRef
6.
go back to reference Huang HY, Daar ES, Sax PE, Young B, Cook P, Benson P, et al. The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection. HIV Med. 2008;9:285–93.CrossRef Huang HY, Daar ES, Sax PE, Young B, Cook P, Benson P, et al. The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection. HIV Med. 2008;9:285–93.CrossRef
7.
go back to reference Pennings PS. HIV drug resistance: problems and perspectives. Infect Dis Rep. 2013;5:e5.CrossRef Pennings PS. HIV drug resistance: problems and perspectives. Infect Dis Rep. 2013;5:e5.CrossRef
8.
go back to reference Frentz D, Boucher CAB, van de Vijver DA. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Rev. 2012;14:17–27.PubMed Frentz D, Boucher CAB, van de Vijver DA. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Rev. 2012;14:17–27.PubMed
9.
go back to reference Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, et al. Swiss HIV Cohort Study (SHCS). Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds. PLoS Path. 2015;11:e1004722.CrossRef Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, et al. Swiss HIV Cohort Study (SHCS). Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds. PLoS Path. 2015;11:e1004722.CrossRef
10.
go back to reference Readhead AC, Gordon DE, Wang Z, Anderson BJ, Brousseau KS, Kouznetsova MA, et al. Transmitted antiretroviral drug resistance in New York state, 2006-2008: results from a new surveillance system. PLoS One. 2012;7:e40533.CrossRef Readhead AC, Gordon DE, Wang Z, Anderson BJ, Brousseau KS, Kouznetsova MA, et al. Transmitted antiretroviral drug resistance in New York state, 2006-2008: results from a new surveillance system. PLoS One. 2012;7:e40533.CrossRef
11.
go back to reference Temereanca A, Ene L, Mehta S, Manolescu L, Duiculescu D, Ruta S. Transmitted HIV drug resistance in treatment-naive Romanian patients. J Med Virol. 2013;85:1139–47.CrossRef Temereanca A, Ene L, Mehta S, Manolescu L, Duiculescu D, Ruta S. Transmitted HIV drug resistance in treatment-naive Romanian patients. J Med Virol. 2013;85:1139–47.CrossRef
12.
go back to reference Vega Y, Delgado E, Fernández-Garcia A, Cuevas MT, Thomson MM, Montero V, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance in Spain in 2004-2012: relevance of transmission clusters in the propagation of resistance mutations. PLoS One. 2015;10:e125699. Vega Y, Delgado E, Fernández-Garcia A, Cuevas MT, Thomson MM, Montero V, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance in Spain in 2004-2012: relevance of transmission clusters in the propagation of resistance mutations. PLoS One. 2015;10:e125699.
13.
go back to reference Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, et al. Update on HIV-1 acquired and transmitted drug resistance in Africa. AIDS Rev. 2015;17:3–20.PubMed Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, et al. Update on HIV-1 acquired and transmitted drug resistance in Africa. AIDS Rev. 2015;17:3–20.PubMed
14.
go back to reference Zhao S, Feng Y, Hu J, Li Y, Zuo Z, Yan J, et al. Prevalence of transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China. Sci Rep. 2018;8:12273.CrossRef Zhao S, Feng Y, Hu J, Li Y, Zuo Z, Yan J, et al. Prevalence of transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China. Sci Rep. 2018;8:12273.CrossRef
15.
go back to reference Zheng MN, Ning TL, Zhou N, Zhao X, Li L, Zhu JJ, et al. Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:619–24.PubMed Zheng MN, Ning TL, Zhou N, Zhao X, Li L, Zhu JJ, et al. Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:619–24.PubMed
16.
go back to reference Wang Z, Zhang M, Zhang R, Liu L, Shen Y, Wang J, et al. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed hiv-infected patients in Shanghai, China. BMC Infect Dis. 2019;19:313.CrossRef Wang Z, Zhang M, Zhang R, Liu L, Shen Y, Wang J, et al. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed hiv-infected patients in Shanghai, China. BMC Infect Dis. 2019;19:313.CrossRef
17.
go back to reference Song YX, Xin RL, Li ZC, Yu HW, Lun WH, Ye J, et al. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing. Epidemiol Infect. 2018;146:339–44.CrossRef Song YX, Xin RL, Li ZC, Yu HW, Lun WH, Ye J, et al. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing. Epidemiol Infect. 2018;146:339–44.CrossRef
18.
go back to reference Li J, Feng Y, Shen Z, Li Y, Tang Z, Xiong R, et al. Author correction: HIV-1 transmissions among recently infected individuals in Southwest China are predominantly derived from circulating local strains. Sci Rep. 2018;8:17478.CrossRef Li J, Feng Y, Shen Z, Li Y, Tang Z, Xiong R, et al. Author correction: HIV-1 transmissions among recently infected individuals in Southwest China are predominantly derived from circulating local strains. Sci Rep. 2018;8:17478.CrossRef
19.
go back to reference Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.CrossRef Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.CrossRef
20.
go back to reference Li X, Xue Y, Lin Y, Gai J, Zhang L, Cheng H, et al. Evolutionary dynamics and complicated genetic transmission network patterns of HIV-1 CRF01_AE among MSM in Shanghai, China. Sci Rep. 2016;6:34729.CrossRef Li X, Xue Y, Lin Y, Gai J, Zhang L, Cheng H, et al. Evolutionary dynamics and complicated genetic transmission network patterns of HIV-1 CRF01_AE among MSM in Shanghai, China. Sci Rep. 2016;6:34729.CrossRef
21.
go back to reference Liu W, Liang SJ, Yang JY, Li JJ, Wang B, Chen LL, et al. Distribution of HIV-1 subtypes in Guangxi Zhuang autonomous region, 2008-2009. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:53–6.PubMed Liu W, Liang SJ, Yang JY, Li JJ, Wang B, Chen LL, et al. Distribution of HIV-1 subtypes in Guangxi Zhuang autonomous region, 2008-2009. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:53–6.PubMed
22.
go back to reference Zhang J, Shen ZY, Li Z, Liang SJ, He C, Liang FX, et al. Genetic characteristics of CRF01_AE among newly diagnosed HIV-1-infected 16- to 25-year olds in 3 geographic regions of Guangxi, China. Medicine. 2015;94:e894.CrossRef Zhang J, Shen ZY, Li Z, Liang SJ, He C, Liang FX, et al. Genetic characteristics of CRF01_AE among newly diagnosed HIV-1-infected 16- to 25-year olds in 3 geographic regions of Guangxi, China. Medicine. 2015;94:e894.CrossRef
23.
go back to reference McClutchan FE, Carr JK, Murphy D, Piyasirisilp S, Gao F, Hahn B, et al. Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retrov. 2002;18:1135–40.CrossRef McClutchan FE, Carr JK, Murphy D, Piyasirisilp S, Gao F, Hahn B, et al. Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retrov. 2002;18:1135–40.CrossRef
24.
go back to reference Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.CrossRef Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.CrossRef
25.
go back to reference Li G, Liang S, Harrison TJ, Tang Z, Shen Z, Wang X, et al. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy. Intervirology. 2014;57:270–6.CrossRef Li G, Liang S, Harrison TJ, Tang Z, Shen Z, Wang X, et al. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy. Intervirology. 2014;57:270–6.CrossRef
26.
go back to reference Han ZG, Zhang YL, Wu H, Gao K, Zhao YT, Gu YZ, et al. Prevalence of drug resistance in treatment-naive HIV infected men who have sex with men in Guangzhou, 2008-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:977–82.PubMed Han ZG, Zhang YL, Wu H, Gao K, Zhao YT, Gu YZ, et al. Prevalence of drug resistance in treatment-naive HIV infected men who have sex with men in Guangzhou, 2008-2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:977–82.PubMed
27.
go back to reference Chen M, Jia MH, Ma YL, Luo HB, Chen HC, Yang CJ, et al. The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China. Epidemiol Infect. 2018;146:775–81.CrossRef Chen M, Jia MH, Ma YL, Luo HB, Chen HC, Yang CJ, et al. The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China. Epidemiol Infect. 2018;146:775–81.CrossRef
28.
go back to reference Wang X, Liu X, Li F, Zhou H, Li J, Wang Y, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, Northern China,2014–2015. PLoS One. 2018;13:e198005. Wang X, Liu X, Li F, Zhou H, Li J, Wang Y, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, Northern China,2014–2015. PLoS One. 2018;13:e198005.
29.
go back to reference Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, et al. Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom. HIV Med. 2017;18:204–13.CrossRef Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, et al. Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom. HIV Med. 2017;18:204–13.CrossRef
30.
go back to reference Hattori J, Shiino T, Gatanaga H, Mori H, Minami R, Uchida K, et al. Characteristics of transmitted drug-resistant HIV-1 in recently infected treatment-naive patients in Japan. J Acquir Immune Defic Syndr. 2016;71:367–73.CrossRef Hattori J, Shiino T, Gatanaga H, Mori H, Minami R, Uchida K, et al. Characteristics of transmitted drug-resistant HIV-1 in recently infected treatment-naive patients in Japan. J Acquir Immune Defic Syndr. 2016;71:367–73.CrossRef
Metadata
Title
HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China
Authors
Xianwu Pang
Kailing Tang
Qin He
Jinghua Huang
Ningye Fang
Xinjuan Zhou
Qiuying Zhu
Xiuling Wu
Zhiyong Shen
Shujia Liang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-05854-w

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue